SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt/ β-catenin signaling.

CONCLUSION: SFRP1 inhibited epithelial ovarian cancer through inhibiting Wnt/β-catenin pathway, suggesting that SFRP1 could be considered as a potential therapeutic target in epithelial ovarian cancer. PMID: 31770484 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31770484?dopt=Abstract

Source: Acta Biochim Pol - November 25, 2019 Category: Biochemistry Authors: Zhang H, Sun D, Qiu J, Yao L Tags: Acta Biochim Pol Source Type: research